Trials / Completed
CompletedNCT00406406
Study Evaluating SKI-606 Administered to Healthy Subjects
Ascending Single Dose Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SKI-606 Administered Orally to Healthy Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- Wyeth is now a wholly owned subsidiary of Pfizer · Industry
- Sex
- All
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
Safety and tolerability of SKI-606 in healthy subjects; the influence of food intake on the same.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | SKI-606 |
Timeline
- Start date
- 2006-11-01
- Completion
- 2007-08-01
- First posted
- 2006-12-04
- Last updated
- 2007-12-05
Locations
1 site across 1 country: Netherlands
Source: ClinicalTrials.gov record NCT00406406. Inclusion in this directory is not an endorsement.